| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 24 | 2021 | 297 | 1.750 |
Why?
|
| Education, Medical, Graduate | 3 | 2017 | 350 | 0.920 |
Why?
|
| Chronic Pain | 3 | 2022 | 156 | 0.890 |
Why?
|
| Virtual Reality | 2 | 2021 | 15 | 0.850 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2014 | 73 | 0.820 |
Why?
|
| Coronary Artery Disease | 9 | 2020 | 320 | 0.820 |
Why?
|
| Personal Satisfaction | 2 | 2014 | 84 | 0.820 |
Why?
|
| Parents | 3 | 2018 | 395 | 0.740 |
Why?
|
| Cystic Fibrosis | 1 | 2022 | 124 | 0.710 |
Why?
|
| Thoracic Surgery | 5 | 2005 | 76 | 0.690 |
Why?
|
| Specialty Boards | 2 | 2017 | 15 | 0.680 |
Why?
|
| Hospitals, Teaching | 2 | 2017 | 106 | 0.650 |
Why?
|
| Nurses, Pediatric | 1 | 2020 | 6 | 0.640 |
Why?
|
| Compassion Fatigue | 1 | 2020 | 13 | 0.630 |
Why?
|
| Computer-Assisted Instruction | 3 | 2005 | 80 | 0.610 |
Why?
|
| Training Support | 2 | 2017 | 22 | 0.600 |
Why?
|
| Postoperative Complications | 11 | 2020 | 1294 | 0.590 |
Why?
|
| Child | 12 | 2022 | 4583 | 0.590 |
Why?
|
| Burnout, Professional | 1 | 2020 | 136 | 0.550 |
Why?
|
| Educational Measurement | 3 | 2016 | 219 | 0.550 |
Why?
|
| Mucopolysaccharidoses | 2 | 2019 | 4 | 0.540 |
Why?
|
| Accreditation | 1 | 2017 | 78 | 0.530 |
Why?
|
| New York | 21 | 2020 | 143 | 0.530 |
Why?
|
| Certification | 1 | 2016 | 57 | 0.490 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 96 | 0.480 |
Why?
|
| Humans | 66 | 2023 | 64238 | 0.470 |
Why?
|
| Financial Management | 1 | 2015 | 6 | 0.470 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 402 | 0.460 |
Why?
|
| Quality of Life | 4 | 2022 | 1257 | 0.450 |
Why?
|
| Registries | 13 | 2020 | 885 | 0.440 |
Why?
|
| Anxiety | 4 | 2022 | 430 | 0.430 |
Why?
|
| Drug-Eluting Stents | 4 | 2020 | 66 | 0.420 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2015 | 160 | 0.420 |
Why?
|
| CD-ROM | 2 | 2004 | 4 | 0.410 |
Why?
|
| Caregivers | 2 | 2014 | 283 | 0.410 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2020 | 270 | 0.410 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2018 | 176 | 0.400 |
Why?
|
| Internship and Residency | 4 | 2017 | 808 | 0.390 |
Why?
|
| Female | 43 | 2022 | 33350 | 0.390 |
Why?
|
| Curriculum | 3 | 2005 | 606 | 0.370 |
Why?
|
| Angioplasty, Balloon, Coronary | 6 | 2012 | 167 | 0.370 |
Why?
|
| Male | 41 | 2022 | 30294 | 0.360 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2020 | 222 | 0.360 |
Why?
|
| Internet | 3 | 2005 | 467 | 0.360 |
Why?
|
| Risk Factors | 25 | 2021 | 5339 | 0.360 |
Why?
|
| Clinical Competence | 1 | 2016 | 728 | 0.350 |
Why?
|
| Adolescent | 10 | 2022 | 6304 | 0.350 |
Why?
|
| Mass Screening | 1 | 2017 | 693 | 0.340 |
Why?
|
| Hospital Mortality | 13 | 2021 | 870 | 0.340 |
Why?
|
| Decision Making | 1 | 2014 | 416 | 0.340 |
Why?
|
| Risk Assessment | 12 | 2020 | 2046 | 0.330 |
Why?
|
| Mitral Valve | 2 | 2018 | 127 | 0.320 |
Why?
|
| Critical Illness | 1 | 2013 | 327 | 0.320 |
Why?
|
| Coronary Disease | 5 | 2013 | 246 | 0.300 |
Why?
|
| Mental Disorders | 1 | 2017 | 794 | 0.300 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 708 | 0.300 |
Why?
|
| United States | 10 | 2021 | 7923 | 0.280 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1118 | 0.280 |
Why?
|
| Time Factors | 16 | 2020 | 3724 | 0.270 |
Why?
|
| Heart Valve Prosthesis | 2 | 2009 | 114 | 0.250 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 190 | 0.250 |
Why?
|
| Physician Executives | 1 | 2005 | 28 | 0.230 |
Why?
|
| Treatment Outcome | 16 | 2023 | 5691 | 0.220 |
Why?
|
| Retrospective Studies | 15 | 2021 | 6726 | 0.220 |
Why?
|
| Funnel Chest | 1 | 2004 | 7 | 0.220 |
Why?
|
| Child, Preschool | 6 | 2020 | 2018 | 0.210 |
Why?
|
| Surgical Mesh | 1 | 2004 | 60 | 0.210 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 71 | 0.210 |
Why?
|
| Aortic Valve | 2 | 2016 | 190 | 0.210 |
Why?
|
| HIV-1 | 3 | 2007 | 723 | 0.210 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2004 | 20 | 0.200 |
Why?
|
| Cardiac Catheterization | 3 | 2016 | 292 | 0.200 |
Why?
|
| Tricuspid Valve | 1 | 2004 | 25 | 0.200 |
Why?
|
| Enzyme Replacement Therapy | 3 | 2019 | 12 | 0.200 |
Why?
|
| Adenoidectomy | 2 | 2020 | 7 | 0.200 |
Why?
|
| Tonsillectomy | 2 | 2020 | 11 | 0.200 |
Why?
|
| Middle Aged | 27 | 2020 | 17898 | 0.200 |
Why?
|
| Aged | 25 | 2020 | 14648 | 0.190 |
Why?
|
| Coronary Vessels | 2 | 2020 | 124 | 0.190 |
Why?
|
| Biofeedback, Psychology | 1 | 2022 | 6 | 0.190 |
Why?
|
| Hospitalization | 3 | 2019 | 1368 | 0.190 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 79 | 0.190 |
Why?
|
| Patient Readmission | 3 | 2021 | 432 | 0.180 |
Why?
|
| Guideline Adherence | 2 | 2018 | 306 | 0.180 |
Why?
|
| Neonatal Screening | 1 | 2022 | 102 | 0.180 |
Why?
|
| Mortality | 2 | 2020 | 161 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 726 | 0.180 |
Why?
|
| Aged, 80 and over | 16 | 2020 | 5520 | 0.180 |
Why?
|
| Radiography, Thoracic | 1 | 2002 | 117 | 0.180 |
Why?
|
| Medical Marijuana | 1 | 2021 | 19 | 0.170 |
Why?
|
| Technology | 1 | 2021 | 53 | 0.170 |
Why?
|
| Infant, Newborn | 2 | 2022 | 1375 | 0.170 |
Why?
|
| Prognosis | 3 | 2022 | 1769 | 0.170 |
Why?
|
| Anesthesiologists | 1 | 2020 | 18 | 0.170 |
Why?
|
| Pain Management | 2 | 2021 | 169 | 0.170 |
Why?
|
| Heart Rate | 1 | 2022 | 327 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2002 | 183 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 197 | 0.160 |
Why?
|
| Patient Handoff | 1 | 2020 | 35 | 0.160 |
Why?
|
| Cannabis | 1 | 2021 | 52 | 0.160 |
Why?
|
| Child Behavior | 1 | 2020 | 64 | 0.150 |
Why?
|
| Chondroitinsulfatases | 1 | 2019 | 1 | 0.150 |
Why?
|
| Mucopolysaccharidosis IV | 1 | 2019 | 1 | 0.150 |
Why?
|
| Reoperation | 2 | 2019 | 291 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1681 | 0.150 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2737 | 0.150 |
Why?
|
| Ventricular Dysfunction | 1 | 2019 | 13 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 197 | 0.150 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2010 | 5 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2021 | 575 | 0.150 |
Why?
|
| Forecasting | 2 | 2017 | 233 | 0.150 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 2478 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2022 | 1019 | 0.140 |
Why?
|
| Analgesics | 1 | 2019 | 102 | 0.140 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2018 | 19 | 0.140 |
Why?
|
| Intensive Care Units | 2 | 2020 | 414 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2018 | 46 | 0.140 |
Why?
|
| Models, Statistical | 2 | 2012 | 309 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 104 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2018 | 86 | 0.140 |
Why?
|
| Pain | 2 | 2021 | 407 | 0.140 |
Why?
|
| Communication Barriers | 1 | 2018 | 68 | 0.130 |
Why?
|
| Organizational Objectives | 1 | 2017 | 58 | 0.130 |
Why?
|
| Capital Financing | 1 | 2017 | 5 | 0.130 |
Why?
|
| Heart Failure | 2 | 2019 | 926 | 0.130 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 95 | 0.130 |
Why?
|
| Disease Management | 1 | 2019 | 237 | 0.130 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2007 | 116 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 117 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2019 | 220 | 0.130 |
Why?
|
| Adult | 9 | 2020 | 17116 | 0.130 |
Why?
|
| Advisory Committees | 1 | 2017 | 113 | 0.130 |
Why?
|
| American Medical Association | 1 | 2016 | 5 | 0.130 |
Why?
|
| Domestic Violence | 1 | 2017 | 39 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 271 | 0.130 |
Why?
|
| Pediatricians | 1 | 2017 | 53 | 0.120 |
Why?
|
| Universities | 1 | 2017 | 164 | 0.120 |
Why?
|
| Fatigue | 1 | 2016 | 114 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2015 | 28 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 438 | 0.110 |
Why?
|
| HIV Infections | 1 | 2002 | 976 | 0.110 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 735 | 0.110 |
Why?
|
| Stents | 2 | 2011 | 493 | 0.110 |
Why?
|
| Medicare | 2 | 2017 | 611 | 0.110 |
Why?
|
| Sternum | 2 | 2004 | 29 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2015 | 151 | 0.110 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 915 | 0.100 |
Why?
|
| Cerebrum | 1 | 2014 | 16 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 214 | 0.100 |
Why?
|
| Angina Pectoris | 1 | 2013 | 38 | 0.100 |
Why?
|
| Young Adult | 3 | 2021 | 4776 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2017 | 368 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 64 | 0.100 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2015 | 112 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2007 | 416 | 0.100 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2010 | 58 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2014 | 218 | 0.090 |
Why?
|
| Health Surveys | 1 | 2013 | 314 | 0.090 |
Why?
|
| Exercise Test | 1 | 2013 | 254 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2016 | 455 | 0.090 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2012 | 17 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 620 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 95 | 0.090 |
Why?
|
| Survival Rate | 5 | 2015 | 859 | 0.090 |
Why?
|
| Medicaid | 1 | 2015 | 362 | 0.090 |
Why?
|
| Psychometrics | 1 | 2013 | 385 | 0.090 |
Why?
|
| Workload | 2 | 2018 | 127 | 0.080 |
Why?
|
| Hospitals | 2 | 2004 | 390 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2017 | 289 | 0.080 |
Why?
|
| Hematocrit | 1 | 2010 | 34 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2014 | 526 | 0.080 |
Why?
|
| Myocardial Revascularization | 2 | 2008 | 76 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 374 | 0.080 |
Why?
|
| Stroke | 1 | 2019 | 1196 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2007 | 93 | 0.080 |
Why?
|
| Hypothermia | 1 | 2010 | 17 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 2 | 2011 | 335 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 122 | 0.080 |
Why?
|
| Fever | 1 | 2010 | 66 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 744 | 0.080 |
Why?
|
| Logistic Models | 5 | 2016 | 1270 | 0.070 |
Why?
|
| Macrophages, Alveolar | 2 | 2007 | 64 | 0.070 |
Why?
|
| Heart Valves | 1 | 2007 | 26 | 0.060 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 163 | 0.060 |
Why?
|
| Virus Replication | 2 | 2007 | 323 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 79 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 137 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 1561 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2013 | 3315 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 245 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2019 | 135 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 2217 | 0.050 |
Why?
|
| Chemokines, CX3C | 1 | 2004 | 4 | 0.050 |
Why?
|
| Chemokines, CC | 1 | 2004 | 13 | 0.050 |
Why?
|
| Osteotomy | 1 | 2004 | 20 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 33 | 0.050 |
Why?
|
| Cartilage | 1 | 2004 | 34 | 0.050 |
Why?
|
| Infant | 2 | 2019 | 1664 | 0.050 |
Why?
|
| California | 2 | 2020 | 175 | 0.050 |
Why?
|
| Referral and Consultation | 2 | 2004 | 428 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2004 | 99 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2005 | 200 | 0.050 |
Why?
|
| Propensity Score | 2 | 2016 | 167 | 0.050 |
Why?
|
| Risk Adjustment | 2 | 2019 | 94 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2012 | 587 | 0.050 |
Why?
|
| Software Design | 1 | 2002 | 28 | 0.050 |
Why?
|
| Prevalence | 2 | 2020 | 1407 | 0.050 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2002 | 39 | 0.050 |
Why?
|
| Aneurysm, Infected | 1 | 2002 | 13 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2002 | 68 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2012 | 856 | 0.040 |
Why?
|
| Los Angeles | 1 | 2021 | 13 | 0.040 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2002 | 108 | 0.040 |
Why?
|
| Retreatment | 1 | 2020 | 44 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1196 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2011 | 759 | 0.040 |
Why?
|
| Length of Stay | 1 | 2004 | 818 | 0.040 |
Why?
|
| Colorado | 1 | 2020 | 21 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 52 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 1102 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 374 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2020 | 209 | 0.040 |
Why?
|
| Hypercapnia | 1 | 2019 | 9 | 0.040 |
Why?
|
| Mucopolysaccharidosis VI | 1 | 2019 | 1 | 0.040 |
Why?
|
| N-Acetylgalactosamine-4-Sulfatase | 1 | 2019 | 1 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 788 | 0.040 |
Why?
|
| Hypnosis, Anesthetic | 1 | 2018 | 1 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 289 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 195 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 67 | 0.040 |
Why?
|
| Tuberculosis | 1 | 2002 | 303 | 0.030 |
Why?
|
| Incidence | 2 | 2015 | 1383 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 293 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 704 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 104 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 285 | 0.030 |
Why?
|
| Coronary Restenosis | 2 | 2008 | 20 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2017 | 68 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2018 | 330 | 0.030 |
Why?
|
| Palliative Care | 1 | 2019 | 239 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1272 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 356 | 0.030 |
Why?
|
| Surgeons | 1 | 2018 | 182 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2002 | 695 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 487 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 239 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 251 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2015 | 209 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2014 | 34 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 144 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 49 | 0.030 |
Why?
|
| Thalamus | 1 | 2014 | 75 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 123 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 979 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 397 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2010 | 46 | 0.020 |
Why?
|
| American Heart Association | 1 | 2010 | 129 | 0.020 |
Why?
|
| Observation | 1 | 2008 | 30 | 0.020 |
Why?
|
| Cardiology | 1 | 2010 | 170 | 0.020 |
Why?
|
| Time | 1 | 2007 | 30 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2007 | 64 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2007 | 16 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2007 | 234 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 1431 | 0.010 |
Why?
|
| Surgery Department, Hospital | 1 | 2004 | 20 | 0.010 |
Why?
|
| Receptors, CCR4 | 1 | 2004 | 4 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 851 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2004 | 30 | 0.010 |
Why?
|
| Utilization Review | 1 | 2003 | 32 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 334 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 944 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 375 | 0.010 |
Why?
|
| Health Services Research | 1 | 2003 | 271 | 0.010 |
Why?
|
| Aortic Rupture | 1 | 2002 | 45 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 1597 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1130 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1997 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 1494 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2176 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 2629 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1551 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1621 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 1669 | 0.010 |
Why?
|